ZUMZ : Summary for Zumiez Inc. - Yahoo Finance

U.S. Markets open in 1 hr 24 mins

Zumiez Inc. (ZUMZ)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
17.20-0.10 (-0.58%)
At close: 4:00PM EDT

17.20 0.00 (0.00%)
Pre-Market: 8:00AM EDT

People also watch
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
Previous Close17.30
Bid0.00 x
Ask0.00 x
Day's Range17.00 - 17.50
52 Week Range13.50 - 26.55
Avg. Volume450,403
Market Cap429.02M
PE Ratio (TTM)16.54
Earnings DateN/A
Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • Zumiez, Inc. :ZUMZ-US: Earnings Analysis: Q4, 2017 By the Numbers : March 24, 2017
    Capital Cube3 days ago

    Zumiez, Inc. :ZUMZ-US: Earnings Analysis: Q4, 2017 By the Numbers : March 24, 2017

    Categories: Yahoo Finance Get free summary analysis Zumiez, Inc. reports financial results for the quarter ended January 31, 2017. We analyze the earnings along side the following peers of Zumiez, Inc. – Tailored Brands, Inc., Buckle, Inc., Tilly’s, Inc. Class A, Express, Inc., Urban Outfitters, Inc., Francesca’s Holdings Corporation, Destination XL Group, Inc., Abercrombie & Fitch Co. Class ... Read more (Read more...)

  • Zacks14 days ago

    Company News for March 13, 2017

    Companies In The News are: ULTA,ZUMZ,HIBB,MTN

  • Barrons.com16 days ago

    [$$] Charting the Market

    H&R Block As the big day approaches, the tax-prep giant reported a narrower-than-expected quarterly loss and seemed to be gaining share in a declining market. American Airlines Group The air carrier lowered its quarterly unit-revenue guidance, a key measure of activity. Concert Pharmaceuticals Vertex Pharmaceuticals will buy the company’s cystic fibrosis treatment for $160 million in cash for development rights, with further payouts possible.